advisorsecurities master

LITSLite Strategy, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key
18074
Ticker
LITS
Type
CSCommon Stock
Exchange
Nasdaq(XNAS)
Venue group
NASDAQ
Operating MIC
XNAS
Market
stocks
Locale
us
Currency
USD
Listed
2003-12-18
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
LITS

Detail

Enriched 2026-08-14 20:47

Market cap
$31,354,221.8
Shares outstanding (class)
34,025,200
Shares outstanding (weighted)
34,025,200
SIC
2834 PHARMACEUTICAL PREPARATIONS
Employees
4
Location
SAN DIEGO, CA
Description

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data